NICHD, Endometriosis, and Female Infertility Research, presented by Linda C. Giudice, MD, PhD, MSc

A recent poll highlights increasing public demand for broader insurance coverage for in vitro fertilization, underscoring persistent barriers faced by millions without access to adequate fertility care.

Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.

A recent study found that COVID-19 infections within 10 weeks after embryo transfer show no correlation with in vitro fertilization pregnancy outcomes.

A recent study revealed a correlation between high doses and prolonged duration of exogenous gonadotropin use during in vitro fertilization and increased embryonic mosaicism alongside diminished live birth rates, prompting reconsideration of dosage and duration protocols.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Discover how FemaSeed, an innovative artificial insemination device by Femasys Inc, offers safe and effective fertility solutions through precise sperm delivery into the fallopian tube.